That wouldn't be too wise in my opinion. Do you really think Walgreens or CVS would ever accept Nyloxin if Cobroxin was discontinued? I'm sure that would go over well.
We wouldn't be discussing this if Rik didn't run his mouth with crazy sale projections. I never believed him and now it has come back to bite him.
Don't get your hopes upon any pipeline drugs. I know you have enough experience to realize there is a high probability none will come to market an even if they do, they are years away. Of course they could stop making Cobroxin, but as their only current revenue source that may be foolish. It will be interesting to see how much Nyloxin is sold in Q3 to HS and the foreign distributors. Hopefully they blow it out! That would be best for all parties and may drop Rik's stress level a little so he releases slightly more professional pr's.
SLB- how does NPHC address their cash burn rate? That is the question I was trying to address.
Also, I am fairly certain Xenacare has paid nominal slotting fees for its shelf space in most the major retailers. This was the hot button issue during the tylenol debacle. J&J paid monster slotting fees on their space in the pain aisle. They threatened CVS & Walgreens when both retailers attempted to fill the empty real estate on the shelf. It was a lose-lose-lose situation for retailers, J&J and Cobroxin.
News 
Market Data 
Discover 
